Choose Language
Select a language for news translation.
Lawmakers’ extended and sometimes unexplained absences from Washington are raising questions about how much transparency elected officials owe the public about…
Ark Invest bought $9.1M of Kratos Defense stock in July, raising its stake to over $110M despite a 33% share drop in 2024. Kratos’ niche in AI-driven drones an…
In a surprise switch, President Trump left Turkey in an older Air Force One plane instead of the Boeing 787 luxury jet donated by Qatar last year, raising ques…
Meta’s Muse Image AI tool lets anyone generate photorealistic photos of public Instagram users without consent unless they manually opt out, raising risks of d…
AI isn't just shaking up workplaces and college classrooms, it's gaining ground among grade school kids and raising parents' concerns.
Tonight there are new questions about what caused the beams in the midtown Manhattan building to buckle, and the floor to sink, raising concerns yesterday abou…
In a memo to employees, Blue Origin CEO Dave Limp said the company is raising the funds at a $130 billion valuation.
AZZ Incorporated's Q1 profit fell to $52 million from $171 million year-over-year, despite a 6.3% revenue increase to $448.5 million. The decline highlights ri…
Traders predict Strait of Hormuz shipping won’t return to normal until January 1, 2027, after Trump ended the U.S.-Iran ceasefire, raising risks of prolonged h…
SpaceX’s stock remains flat at its IPO price of $150, reflecting investor doubts about its ambitious projects despite bullish analyst targets. Blue Origin is r…
The FDA approved Ionis Pharmaceuticals’ Tryngolza, raising its stock price target to $130, while enrollment began for a Phase 3 trial of obudanersen (ION582) t…
